Evergreen Capital Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $611K | Buy |
39,523
+8,520
| +27% | +$132K | 0.02% | 482 |
|
|
2025
Q1 | $461K | Sell |
31,003
-6,382
| -17% | -$94.9K | 0.02% | 544 |
|
|
2024
Q4 | $495K | Buy |
37,385
+24,583
| +192% | +$325K | 0.02% | 516 |
|
|
2024
Q3 | $182K | Buy |
+12,802
| New | +$182K | 0.01% | 953 |
|
|
2024
Q2 | – | Sell |
-13,774
| Closed | -$191K | – | 990 |
|
|
2024
Q1 | $191K | Buy |
+13,774
| New | +$191K | 0.01% | 804 |
|
|
2023
Q4 | – | Sell |
-10,466
| Closed | -$162K | – | 900 |
|
|
2023
Q3 | $162K | Sell |
10,466
-3,506
| -25% | -$54.2K | 0.01% | 729 |
|
|
2023
Q2 | $220K | Buy |
13,972
+446
| +3% | +$7.01K | 0.01% | 686 |
|
|
2023
Q1 | $223K | Buy |
+13,526
| New | +$223K | 0.01% | 622 |
|
|
2022
Q4 | – | Sell |
-17,574
| Closed | -$228K | – | 708 |
|
|
2022
Q3 | $228K | Buy |
17,574
+4,186
| +31% | +$54.3K | 0.01% | 517 |
|
|
2022
Q2 | $188K | Buy |
13,388
+2,274
| +20% | +$31.9K | 0.01% | 531 |
|
|
2022
Q1 | $159K | Buy |
+11,114
| New | +$159K | 0.01% | 632 |
|